VENTOLIN HFA (albuterol sulfate) Glaxosmithkline Patent: 9,861,771 Expiration: Oct 11, 2020 See More … For more information on how DrugPatentWatch […]
Drug Patent Expirations for the Week of October 11, 2020 Read Post »
Annual Drug Patent Expirations for LESCOL+XL Lescol Xl is a drug marketed by Novartis and is included in one NDA.
New patent expiration for Novartis drug LESCOL XL Read Post »
Annual Drug Patent Expirations for MOXATAG Moxatag is a drug marketed by Pragma and is included in one NDA. There
Annual Drug Patent Expirations for ADVAIR+HFA Advair Hfa is a drug marketed by Glaxo Grp Ltd and is included in
New patent expiration for Glaxo Grp drug ADVAIR HFA Read Post »
Annual Drug Patent Expirations for FLOVENT+HFA Flovent Hfa is a drug marketed by Glaxo Grp Ltd and is included in
New patent expiration for Glaxo Grp drug FLOVENT HFA Read Post »
Annual Drug Patent Expirations for VENTOLIN+HFA Ventolin Hfa is a drug marketed by Glaxosmithkline and is included in one NDA.
New patent expiration for Glaxosmithkline drug VENTOLIN HFA Read Post »
Annual Drug Patent Expirations for PICATO Picato is a drug marketed by Leo Labs and is included in one NDA.
BYDUREON PEN (exenatide synthetic) Astrazeneca ab Patent: 9,198,925 Expiration: Oct 4, 2020 See More … For more information on how
Drug Patent Expirations for the Week of October 4, 2020 Read Post »
Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA.
New patent expiration for Astrazeneca Ab drug FARXIGA Read Post »
Get fresh news and insights, drug patent expirations & more…
